← FDA Drug Approvals (Drugs@FDA)

ENZALUTAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2026-04-20

Drug application

FDA Application #

ANDA216068

Application type

Abbreviated New Drug Application (Generic)

Brand name

ENZALUTAMIDE

Generic name

Enzalutamide

Active ingredients

ENZALUTAMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SANDOZ

First approval

2026-04-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown